By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


G1 Therapeutics 

79 T.W. Alexander Drive
4501 Research Commons, Suite 100
Chapel Hill  North Carolina    U.S.A.
Phone: 919-213-9835 Fax: 919-741-5830



Company News
G1 Therapeutics (GTHX) Announces Closing Of Initial Public Offering 5/23/2017 10:41:14 AM
Cancer Biotech G1 Therapeutics (GTHX) Grabs $105 Million in IPO 5/17/2017 6:11:26 AM
G1 Therapeutics Announces Launch Of Initial Public Offering 5/8/2017 9:06:19 AM
Cancer Biotech G1 Therapeutics Files for $115 Million IPO 4/18/2017 6:36:42 AM
G1 Therapeutics Release: Biotech Initiates Three Drug Development Programs In Breast Cancer 1/10/2017 7:00:07 AM
G1 Therapeutics To Evaluate Trilaciclib (G1T28) In Combination With Immune Checkpoint Inhibitor In Small-Cell Lung Cancer 12/5/2016 8:45:09 AM
G1 Therapeutics To Present At Wedbush PacGrow Healthcare Conference 8/10/2016 10:57:45 AM
University of North Carolina Spinout G1 Therapeutics Locks in $47 Million Series C Financing 5/12/2016 6:37:54 AM
G1 Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference 2/2/2016 11:21:38 AM
G1 Therapeutics To Present At The Stifel 2015 Healthcare Conference 11/10/2015 8:36:04 AM